SJS Investment Consulting’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SJS Investment Consulting's PFE Position: Q3 2026 in Review
SJS Investment Consulting increased its Pfizer (PFE) stake by 205% in Q3 2026, buying an estimated $299K and bringing the position to 16,708 shares worth $477K. The position accounts for 0.05% of the portfolio, ranked #100.
SJS Investment Consulting first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- SJS Investment Consulting held 16,708 shares of Pfizer worth $477K as of Q3 2026.
- SJS Investment Consulting bought 11,226 Pfizer shares in Q3 2026, an estimated $299K.
- Pfizer made up 0.05% of SJS Investment Consulting's portfolio in Q3 2026, its #100 holding.
- SJS Investment Consulting first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.